The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Costs of skeletal-related events (SREs) in patients with metastatic castrate-resistant prostate cancer (mCRPC) treated with oral therapies.
 
Nicole Engel-Nitz
Employment - Optum/UnitedHealth Group
Stock and Other Ownership Interests - Optum/UnitedHealth Group
Research Funding - Alexion Pharmaceuticals (Inst); ARIAD (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Merck (Inst); Novartis (Inst)
 
Ajay S. Behl
Employment - Janssen Scientific Affairs
Stock and Other Ownership Interests - Johnson & Johnson
 
Cori Blauer-Peterson
Employment - Optum/UnitedHealth Group
Stock and Other Ownership Interests - United Health Group
 
Sophia S Li
Employment - Becton Dickinson; Janssen Scientific Affairs
Stock and Other Ownership Interests - Becton Dickinson; Johnson & Johnson
 
Nancy Ann Dawson
Honoraria - Amgen; Astellas Pharma; Bayer; Eisai; Genentech/Roche; Janssen Biotech; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Janssen Scientific Affairs
Speakers' Bureau - Amgen; Astellas Pharma; Bayer; Dendreon; Eisai; Genentech/Roche; Janssen Biotech; Novartis; Pfizer; Sanofi
Research Funding - Acceleron Pharma (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Pfizer (Inst); Roche/Genentech (Inst); Tokai Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Caris Life Sciences